Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  The Lancet

• Publication date

  2007-02-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(07)60234-7PMID 17292766
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Unmet Needs in Non-steroidal Anti-inflammatory Drug-induced Upper Gastrointestinal Diseases

  2012cited by this paper
• Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis.

  2006cited by this paper
• Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.

  2006cited by this paper
• Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.

  2006cited by this paper
• LPS MODULATES THE EXPRESSION OF GCRα AND GCRβ ON K562 CELLS: 33

  2006cited by this paper
• The impact of low‐dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non‐selective non‐steroidal anti‐inflammatory drug or a cyclo‐oxygenase‐2‐selective inhibitor

  2006cited by this paper
• Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.

  2005cited by this paper
• Improvements with Esomeprazole in Patients with Upper Gastrointestinal Symptoms Taking Non-Steroidal Antiinflammatory Drugs, Including Selective COX-2 Inhibitors

  2005cited by this paper
• Meta‐analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase‐2‐specific inhibitor, compared with nonspecific nonsteroidal anti‐inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis

  2005cited by this paper
• Valdecoxib Is Associated with Improved Dyspepsia-Related Health Compared with Nonspecific NSAIDs in Patients with Osteoarthritis or Rheumatoid Arthritis

  2005cited by this paper
• A Randomized Double-blind Placebo-controlled Trial

  2004cited by this paper
• Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial.

  2004cited by this paper
• Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial.

  2004cited by this paper
• Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs--nice or necessary?

  2004cited by this paper
• Guidelines for the appropriate use of non‐steroidal anti‐inflammatory drugs, cyclo‐oxygenase‐2‐specific inhibitors and proton pump inhibitors in patients requiring chronic anti‐inflammatory therapy

  2004cited by this paper
• Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial.

  2003cited by this paper
• Gastrointestinal health care resource utilization with chronic use of COX-2-specific inhibitors versus traditional NSAIDs.

  2003cited by this paper
• Guidelines for the management of oesophageal and gastric cancer

  2002cited by this paper
• Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis.

  2002cited by this paper
• Dyspepsia tolerability from the patients' perspective: a comparison of celecoxib with diclofenac

  2002cited by this paper
• Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.

  2002cited by this paper
• Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis

  2002cited by this paper
• Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial

  2002cited by this paper
• Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.

  2001cited by this paper
• Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs.

  2001cited by this paper
• Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.

  2001cited by this paper
• Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.

  2000cited by this paper
• Comparative Inhibitory Activity of Rofecoxib, Meloxicam, Diclofenac, Ibuprofen, and Naproxen on COX‐2 versus COX‐1 in Healthy Volunteers

  2000cited by this paper
• Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

  2000cited by this paper
• Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

  2000cited by this paper
• Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis.

  2000cited by this paper
• Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

  1999cited by this paper
• A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.

  1998cited by this paper
• Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs.

  1997cited by this paper
• Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs

  1995cited by this paper
• Dyspepsia in NSAID Users: The Size of the Problem

  1989cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs.

  1987cited by this paper

• Evaluating adverse events reported for non-steroidal anti-inflammatory drugs in osteoarthritis: a real-world pharmacovigilance study.

  2026cites this paper
• Osteoporotic Compression Fracture with Anterolisthesis in a Geriatric Diabetic Patient: A Conservative Management Approach

  2025cites this paper
• Cost-utility analysis of duloxetine in osteoarthritis: from Chinese healthcare perspective

  2024cites this paper
• Medical eponyms versus acronyms: what medical terminology is most beneficial to learn? A question of goals.

  2024cites this paper
• Low Frequency of Upper Gastrointestinal Bleeding Despite Non-Steroidal Anti-Inflammatory Drugs and Corticosteroids in Patients with Rheumatoid Arthritis.

  2024cites this paper
• The Prevalence, Etiology and Treatment of Gastroduodenal Ulcers and Perforation: A Systematic Review

  2024cites this paper
• Reduction of systemic exposure and side effects by intra-articular injection of anti-inflammatory agents for osteoarthritis: what is the safer strategy?

  2023cites this paper
• A systematic review and network meta-analysis of pharmaceutical interventions used to manage chronic pain

  2023cites this paper
• Impact of Preventive Strategies on Gastrointestinal Complications in Elderly Patients on Concomitant Use of Oral Anticoagulants and Nonsteroidal Anti-Inflammatory Drugs: A Nationwide Cohort Study

  2022cites this paper
• Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials

  2022cites this paper
• [Evaluation of the efficacy and safety of Dolocox in patients with nonspecific back].

  2022cites this paper
• SHORT- AND LONG-TERM EFFECTS OF NSAIDS ON THE GASTROINTESTINAL MUCOSA: COMPLEX ANALYSIS OF BENEFITS AND COMPLICATIONS PREVENTION.

  2021cites this paper
• Features of NSAIDs' use in pandemic. Gastroenterologist's view

  2021cites this paper
• Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis

  2021cites this paper
• Pulsed Shortwave Therapy in Cervical Osteoarthritis: an NSAID- Controlled, Randomized Clinical Trial

  2020cites this paper
• Adverse reactions with the use of non-steroidal anti-inflammatory drugs

  2020cites this paper
• 비스테로이드소염제를 투약하는 환자에서 소화성궤양의 예방

  2020cites this paper
• Start therapy of pain at gonarthrosis in patients with diabetes mellitus

  2020cites this paper
• Toxicité gastroduodénale des médicaments anti-inflammatoires non stéroïdiens

  2020cites this paper
• Etoricoxib in the treatment of osteoarthritis

  2020cites this paper
• Practice Advisory on the Appropriate Use of NSAIDs in Primary Care

  2020cites this paper
• Aspirin and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

  2020cites this paper
• Стартовая терапия боли при гонартрозе у больных сахарным диабетом

  2020cites this paper
• Process control and scale-up of modified bacterial cellulose production for tailor-made anti-inflammatory drug delivery systems.

  2020cites this paper
• Nichtopioidanalgetika in der Anästhesiologie

  2019cites this paper
• A JOURNEY OF CELECOXIB FROM PAIN TO CANCER.

  2019cites this paper
• Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment

  2019cites this paper
• A model to predict the risk of aspirin/non‐steroidal anti‐inflammatory drugs‐related upper gastrointestinal bleeding for the individual patient

  2019cites this paper
• A model to predict the risk of aspirin/NSAID-related upper gastrointestinal bleeding for the individual patient

  2019cites this paper
• Nonsteroidal Anti-Inflammatory Drug-Gastropathy and Enteropathy

  2019cites this paper
• Nonsteroidal Anti-inflammatory Drugs

  2019cites this paper
• Adverse Effects of Etoricoxib, a Selectively Inhibiting Cyclo-Oxygenase-2 Anti-Inflammatory Drug, Assessed on Ants Used as a Model

  2019cites this paper
• Cardiac toxicity of coxibs: mechanisms of development and their prevention

  2018cites this paper
• Editorial: gastrointestinal safety of COX‐2 selective and nonselective NSAIDs—the impact of the PRECISION trial

  2018cites this paper
• Safety of treatment options for spondyloarthritis: a narrative review

  2018cites this paper
• Gastrointestinal safety of coxibs: systematic review and meta‐analysis of observational studies on selective inhibitors of cyclo‐oxygenase 2

  2018cites this paper
• Do glucocorticoids affect the development of ulcers and erosions of the upper gastrointestinal tract in patients taking NSAIDs.

  2018cites this paper
• Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac

  2018influential citation
• Cardiovascular Risk of Nonsteroidal Anti‐inflammatory Drugs and Classical and Selective Cyclooxygenase‐2 Inhibitors: A Meta‐analysis of Observational Studies

  2018cites this paper
• Топические формы диклофенака в лечении заболеваний опорно-двигательного аппарата

  2018cites this paper
• Gelenk- und Muskelschmerzen

  2018cites this paper
• Gastrointestinal Complications of Antirheumatic Drugs

  2017cites this paper
• Nicht steroidale Antirheumatika und gastrointestinales Risiko

  2017cites this paper
• Non-steroidal anti-inflammatory drug related upper gastrointestinal bleeding: types of drug use and patient profiles in real clinical practice

  2017cites this paper
• Celecoxib for rheumatoid arthritis.

  2017cites this paper
• Toxicité gastroduodénale des médicaments anti-inflammatoires non stéroïdiens

  2017cites this paper
• A comparative evaluation of diclofenac sodium transdermal patch, oral diclofenac sodium with intramuscular injections of diclofenac sodium in patients suffering from oral pain: A randomized control trial

  2017cites this paper
• Status of etoricoxib in the treatment of rheumatic diseases. Expert panel opinion

  2017cites this paper
• Efficacy and Safety of Proton Pump Inhibitors in the Long-Term Aspirin Users: A Meta-Analysis of Randomized Controlled Trials

  2017cites this paper
• Systematic review with meta‐analysis: the gastrointestinal benefits of COX‐2 selective inhibitors with concomitant use of low‐dose aspirin

  2016cites this paper
• Title: Systematic review with meta-analysis: the gastrointestinal benefit of COX-2 selective inhibitors with concomitant use of low-dose aspirin Running title: Coxib gastrointestinal benefit with aspirin use

  2016cites this paper
• Balancing cardiovascular and gastrointestinal risks in patients with osteoarthritis receiving nonsteroidal anti‑inflammatory drugs. A summary of guidelines from an international expert group.

  2016cites this paper
• Approach to Suspected Nonvariceal Upper Gastrointestinal Bleeding

  2016cites this paper
• Glucosamina y sulfato de condroitina en el tratamiento de la osteoartritis

  2016cites this paper
• FORMACION CONTINUADA - TERAPEUTICA EN ATENCION PRIMARIA

  2016cites this paper
• DGRh-Empfehlungen zur Implementierung aktueller Sicherheitsaspekte in die NSAR- Therapie muskuloskelettaler Schmerzen

  2016cites this paper
• Perioperative blood loss and gastrointestinal tolerability of etoricoxib and diclofenac in total hip arthroplasty (ETO-DIC study): a single-center, prospective double-blinded randomized controlled trial

  2016cites this paper
• Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac

  2016cites this paper
• A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis

  2016cites this paper
• Adverse Effects of NSAIDs in the Gastrointestinal Tract: Risk Factors of Gastrointestinal Toxicity with NSAIDs

  2016cites this paper
• NSAR in der Schmerztherapie

  2016cites this paper
• DGRh-Empfehlungen zur Implementierung aktueller Sicherheitsaspekte in die NSAR-Therapie muskuloskelettaler Schmerzen

  2016cites this paper
• A randomised, double‐blinded study comparing giving etoricoxib vs. placebo to female patients with fibromyalgia

  2016cites this paper
• Evolution to low-dose NSAID therapy.

  2016cites this paper
• Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants.

  2015cites this paper
• Medikamenten-induzierte Oberbauchbeschwerden

  2015cites this paper
• Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury

  2015cites this paper
• Diagnosis and therapy of non-variceal upper gastrointestinal bleeding.

  2015cites this paper
• [Efficiency and safety of different etoricoxib regimens in patients with axial spondyloarthritis, including ankylosing spondylitis].

  2015cites this paper
• [Clinical guidelines «Rational use of nonsteroidal anti-inflammatory drugs (NSAIDs) in clinical practice». Part II].

  2015cites this paper
• The perceptual and anti-Inflammatory effects of oleocanthal, an olive oil phenolic

  2015cites this paper
• NSAR in der Schmerztherapie

  2015cites this paper
• Европейские и международные рекомендации по алгоритму лечения остеоартрита коленного сустава: отчет рабочей группы Европейского общества по клиническим и экономическим аспектам остеопороза и остеоартрита (ESCEO)

  2015cites this paper
• Peptic ulcer disease.

  2015cites this paper
• Monitoring ankylosing spondylitis: clinically useful markers and prediction of clinical outcomes

  2015cites this paper
• Treatment of ankylosing spondylitis.

  2015cites this paper
• Safety of Etoricoxib, Celecoxib, and Nonselective Nonsteroidal Antiinflammatory Drugs in Ankylosing Spondylitis and Other Spondyloarthritis Patients: A Swedish National Population‐Based Cohort Study

  2015cites this paper
• Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis – an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks

  2015cites this paper
• NSAID-Induced Enteropathy: Are the Currently Available Selective COX-2 Inhibitors All the Same?

  2014cites this paper
• Bacterial cellulose membranes as transdermal delivery systems for diclofenac: in vitro dissolution and permeation studies.

  2014cites this paper
• Efficacy and Safety of Celecoxib in Chinese Patients with Ankylosing Spondylitis: A 6-Week Randomized, Double-Blinded Study with 6-Week Open-Label Extension Treatment

  2014cites this paper
• An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

  2014cites this paper
• Gastrointestinal Adverse Drug Reactions

  2014cites this paper
• Information for rational drug prescribing to older patients : Availability and applicability

  2014cites this paper
• Etoricoxib in the treatment of active sacroiliitis in patients with axial spondyloarthritis, including ankylosing spondylitis

  2014cites this paper
• Cost-Effectiveness Analysis of Celecoxib in the Treatment of Patients with Chronic Pain in Japan

  2014cites this paper
• Evaluación clínica del paciente con artrosis: estudio multicéntrico nacional "EVALÚA"

  2014cites this paper
• Content of nitrogen oxide synthases in the mucosa of the stomach and duodenum of patients with NSAID gastropathy

  2014cites this paper
• [Etoricoxib in the treatment of active sacroiliitis in patients with axial spondyloarthritis, including ankylosing spondylitis].

  2014cites this paper
• Endoscopic management of acute peptic ulcer bleeding.

  2014cites this paper
• Y a-t-il une place pour les inhibiteurs de la COX-2 en péri-opératoire ?

  2014cites this paper
• Transdermal delivery of pH responsive liposomes containing indomethacin for the treatment of Rheumatoid Arthritis

  2013cites this paper
• Proton pump inhibitors in acid-related diseases. Issues in diagnosis, treatment and outcome

  2013cites this paper
• Management of Hyperuricemia and Gout

  2013cites this paper
• A Review of the Efficacy, Safety, and Cost‐Effectiveness of COX‐2 Inhibitors for Africa and the Middle East Region

  2013cites this paper
• Lower gastrointestinal adverse effects of NSAIDS: an extreme example of a common problem

  2013cites this paper
• Cost-Effectiveness Analyses of Osteoarthritis Oral Therapies: a Systematic Review

  2013influential citation
• Renal Effects of Non-Steroidal Anti Inflammatory Drugs in Albino Rats

  2013cites this paper
• The cost-effectiveness of duloxetine in chronic low back pain: a US private payer perspective.

  2013cites this paper
• Cost-Utility Analysis of Duloxetine in Osteoarthritis: A US Private Payer Perspective

  2013cites this paper